Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Papers of the Week
Annotation


Smith GS, Laxton AW, Tang-Wai DF, McAndrews MP, Diaconescu AO, Workman CI, Lozano AM. Increased Cerebral Metabolism After 1 Year of Deep Brain Stimulation in Alzheimer Disease. Arch Neurol. 2012 May 7; PubMed Abstract

  
Comments on Paper and Primary News
  Comment by:  Michele York
Submitted 11 May 2012  |  Permalink Posted 11 May 2012

Dr. Lozano’s study demonstrating increased cerebral glucose metabolism one year following deep-brain stimulation for Alzheimer’s disease is an exciting advancement in the development of a treatment for the cognitive and neuropsychiatric symptoms of AD. The findings of a relationship between improvements in outcome (although minor) and increased metabolism strengthens the researchers' argument that a larger study is needed to further evaluate the efficacy of this intervention. It should be noted that in this very small sample, the patients were younger and less cognitively impaired than the majority of AD patients seen in clinical populations. However, as a proof-of-concept and tolerability study, these findings provide the impetus needed for further investigation. This avenue of research will require a large, well-controlled, and thoroughly described investigation with both short- and long-term safety and efficacy outcomes in a sample that can be generalized to a wider AD population prior to it being offered as a therapeutic intervention.

View all comments by Michele York

  Comment by:  Katja Hardenacke, Jens Kuhn
Submitted 24 May 2012  |  Permalink Posted 24 May 2012

Since the end of the 1980s, deep-brain stimulation (DBS) has substantially expanded the therapeutically possibilities of treating Parkinson’s disease (1). DBS refers to a complex neuromodulative procedure, which implies the stereotactical implantation of two electrodes into defined target structures of the brain. The success story told by DBS in the field of movement disorders, the minimally invasive surgery and the rare and usually very minor side effects, suggest that the ambitions of applying DBS to other neurological and psychiatric indications will be more quickly fulfilled in the future (2). And indeed, in the last three years two groups (3-6) (see also http://clinicaltrials.gov/ct2/show/NCT01094145) employed DBS has been used with the aim of improving cognitive abilities in patients with dementia.

Despite many years of experience with DBS, the therapeutic mechanisms are not yet completely understood. There are various actions being discussed, since, on the neuronal level, excitatory and...  Read more

  Submit a Comment on this Paper
Cast your vote and/or make a comment on this paper. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend this paper

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
 
 
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad